These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29905971)

  • 1. Impact of insurance type on eligibility for advanced heart failure therapies and survival.
    Hutcheson SS; Phillips V; Patzer R; Smith A; Vega JD; Morris AA
    Clin Transplant; 2018 Aug; 32(8):e13328. PubMed ID: 29905971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities and Impact of Medicaid Expansion on Left Ventricular Assist Device Implantation and Outcomes.
    Wang X; Luke AA; Vader JM; Maddox TM; Joynt Maddox KE
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006284. PubMed ID: 32394720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in eligibility for advanced heart failure therapies.
    Steinberg RS; Nayak A; O'Connell C; Burford S; Pekarek A; Chesnut N; Cole RT; Gupta D; Laskar SR; Bhatt K; Burke M; Attia T; Smith A; Vega JD; Morris AA
    Clin Transplant; 2020 May; 34(5):e13839. PubMed ID: 32073188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of insurance status on heart transplant wait-list mortality for patients with left ventricular assist devices.
    Emani S; Tumin D; Foraker RE; Hayes D; Smith SA
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27862317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Socioeconomic Status on Patients Supported With a Left Ventricular Assist Device: An Analysis of the UNOS Database (United Network for Organ Sharing).
    Clerkin KJ; Garan AR; Wayda B; Givens RC; Yuzefpolskaya M; Nakagawa S; Takeda K; Takayama H; Naka Y; Mancini DM; Colombo PC; Topkara VK
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Evaluations for Heart Transplant Before Durable Left Ventricular Assist Device and Subsequent Receipt of Transplant at Transplant vs Nontransplant Centers.
    Cascino TM; McCullough JS; Wu X; Pienta MJ; Stewart JW; Hawkins RB; Brescia AA; Abou El Ala A; Zhang M; Noly PE; Haft JW; Cowger JA; Colvin M; Aaronson KD; Pagani FD; Likosky DS;
    JAMA Netw Open; 2022 Nov; 5(11):e2240646. PubMed ID: 36342716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Health Insurance Payer Type and Outcomes After Durable Left Ventricular Assist Device Implantation: An Analysis of the STS-INTERMACS Registry.
    Khatana SAM; Hanff TC; Nathan AS; Dayoub EJ; Grandin EW; Rame JE; Fanaroff AC; Giri J; Groeneveld PW
    Circ Heart Fail; 2021 May; 14(5):e008277. PubMed ID: 33993721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of medication non-adherence on survival after pediatric heart transplantation in the U.S.A.
    Oliva M; Singh TP; Gauvreau K; Vanderpluym CJ; Bastardi HJ; Almond CS
    J Heart Lung Transplant; 2013 Sep; 32(9):881-8. PubMed ID: 23755899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Dual Eligibility for Medicare and Medicaid With Heart Failure Quality and Outcomes Among Get With The Guidelines-Heart Failure Hospitals.
    Bahiru E; Ziaeian B; Moucheraud C; Agarwal A; Xu H; Matsouaka RA; DeVore AD; Heidenreich PA; Allen LA; Yancy CW; Fonarow GC
    JAMA Cardiol; 2021 Jul; 6(7):791-800. PubMed ID: 33825802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and Cost of Heart Transplantation and Left Ventricular Assist Devices: Impact of Proposed Federal Cuts.
    Patel N; Kalra R; Doshi R; Bajaj NS; Arora G; Arora P
    JACC Heart Fail; 2018 May; 6(5):424-432. PubMed ID: 29724365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.
    Mulloy DP; Bhamidipati CM; Stone ML; Ailawadi G; Kron IL; Kern JA
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):566-73; discussion 573-4. PubMed ID: 23246055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redo sternotomy versus left ventricular assist device explant as risk factors for early mortality following heart transplantation.
    Ribeiro RVP; Alvarez JS; Fukunaga N; Yu F; Adamson MB; Foroutan F; Cusimano RJ; Yau T; Ross H; Alba AC; Billia F; Badiwala MV; Rao V
    Interact Cardiovasc Thorac Surg; 2020 Nov; 31(5):603-610. PubMed ID: 33137824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.
    Truby LK; Farr MA; Garan AR; Givens R; Restaino SW; Latif F; Takayama H; Naka Y; Takeda K; Topkara VK
    Circulation; 2019 Aug; 140(6):459-469. PubMed ID: 31203669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry.
    Ambardekar AV; Forde-McLean RC; Kittleson MM; Stewart GC; Palardy M; Thibodeau JT; DeVore AD; Mountis MM; Cadaret L; Teuteberg JJ; Pamboukian SV; Cantor RS; Lindenfeld J
    J Heart Lung Transplant; 2016 Jun; 35(6):722-30. PubMed ID: 26987599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous-Flow Left Ventricular Assist Devices.
    Asleh R; Alnsasra H; Daly RC; Schettle SD; Briasoulis A; Taher R; Dunlay SM; Stulak JM; Behfar A; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Kushwaha SS
    J Am Heart Assoc; 2019 Nov; 8(22):e013108. PubMed ID: 31701791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insurance and education predict long-term survival after orthotopic heart transplantation in the United States.
    Allen JG; Weiss ES; Arnaoutakis GJ; Russell SD; Baumgartner WA; Shah AS; Conte JV
    J Heart Lung Transplant; 2012 Jan; 31(1):52-60. PubMed ID: 21959122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
    Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E
    Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure.
    Lala A; Rowland JC; Ferket BS; Gelijns AC; Bagiella E; Pinney SP; Moskowitz AJ; Miller MA; Pagani FD; Mancini DM
    JAMA Cardiol; 2020 Jun; 5(6):652-659. PubMed ID: 32293643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in status 2 patients listed for heart transplantation in the United States: Will understanding cause of death help justify implantation of left ventricular assist devices into less sick patients?
    Morris AA; Chen C; Laskar SR; Smith AL; Vega JD
    Int J Cardiol; 2019 Feb; 276():185-190. PubMed ID: 30482444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.